同时性多原发结直肠癌诊疗进展  

Progress in the Diagnosis and Treatment of Synchronous Colorectal Cancers

作　　者：涂利文 赵书峰 曾祥福 

机构地区：[1]赣南医科大学第一临床医学院,江西 赣州 [2]赣南医科大学第一附属医院胃肠外科,江西 赣州

出　　处：《临床医学进展》2024年第12期335-340,共6页Advances in Clinical Medicine

摘　　要：随着人均寿命的增长及医疗水平的进步,同时性多原发结直肠癌(synchronous colorectal cancers, SCRC)的发病率及检出率均有增多趋势。目前SCRC约占结直肠癌的1.1%~8.1%,且有上升的趋势。对SCRC的诊疗方法国内外尚无统一的共识,目前SCRC的治疗原则上同结直肠癌,早期行根治性切除术是首要目标。本文将简要概述SCRC的诊疗现状,并从手术治疗和新辅助治疗等方面对近期国内外SCRC相关的研究成果进行综述。With the increase of average life expectancy and the progress of medical level, the incidence and detection rate of synchronous colorectal cancers (SCRC) increase, accounting for about 1.1%~8.1% of colorectal cancer currently, and has an increasing trend. There is no unified consensus on the diagnosis and treatment method of SCRC at home and abroad. In principle, the treatment of SCRC should be the same as that of colorectal cancer, and early radical resection is the primary goal. This paper will give a brief overview of the current status of SCRC diagnosis and treatment, and review the recent research results of SCRC at home and abroad from the aspects of surgical treatment and neoadjuvant therapy.

关 键 词：同时性 多原性 结直肠癌 诊疗 

分 类 号：R73[医药卫生—肿瘤]